Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY-NC-ND 4.0ACS Omega

Niacinamide–Ceramide Conjugate: In Vitro Bioactivities and 28-Day Clinical Evidence for Multitarget Skincare

  1. 1Guangdong Pharmaceutical University, Education Mega Centre , , No. 280, Waihuandong Road , ,
  2. 2Shenzhen Dieckmann Biotechnology Co., Ltd. , Building 2A, 10 F Zhongcheng Biomedical Industrial Park, Pingshan District , ,

Abstract

Niacinamide (NAM) and ceramides are well-established skincare ingredients with distinct yet complementary biological mechanisms. Nevertheless, simple physical blending of these two actives presents practical limitations for topical application. To address this, the present study evaluated SuperCera N-Nicotinamide(P) (NAM-Cer), a niacinamide–ceramide covalent conjugate conceived to integrate bioactivities derived from each parent moiety within a single molecular framework. Employing an integrated workflow combining in vitro cellular assays and a 28-day randomized clinical trial, we identified multiple cellular-level bioactivities of NAM-Cer, including elastase inhibition, upregulation of type I collagen (COL1A1) and aquaporin-3 (AQP3), suppression of melanogenesis and tyrosinase activity, and downregulation of matrix metalloproteinase-1 (MMP-1). Clinical evaluation revealed significant, concentration-dependent improvements in skin hydration, elasticity, firmness, brightness, and antiwrinkle efficacy, along with favorable cutaneous tolerability. In summary, NAM-Cer is a safe, multitarget skincare candidate that elicits diverse skin-beneficial bioactivities in vitro and drives concentration-dependent cutaneous improvements in short-term human topical use.

Related

  1. Lipid Matrix-Dependent Effects of Ceramide Enrichment on Cholesterol-Containing PSM and DLPC Membranes
    Eun Sub Song, Taejin Kwon
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
  2. StereoAtlas: A Large-Scale Dataset of Chiral Compounds with Distinct Bioactivities Curated from ChEMBL37
    Saisaran Thangaraj, N. Arul Murugan, Arul Murugan Natarajan
    ChemRxivPreprintCC BYFull textGeneral chemistryChemRxiv
  3. Ultrasound-Assisted Aqueous Extraction of Origanum sipyleum and Sideritis pisidica: LC–MS/MS Phenolic Profiles and Bioactivities
    Ümmühan Ünlü
    MoleculesPeer-reviewedCC BY 4.0General chemistryCrossref
  4. Chemical Composition and Multiple Bioactivities of Ageratum conyzoides Essential Oil Collected in Dak Lak, Vietnam
    Thi Kim An Nguyen, Manh Ha Nguyen, Truong Nhan Ngu +8
    Journal of Oleo SciencePeer-reviewedCC BYFull textGeneral chemistryJ-STAGE
  5. Chemical Composition and In Vitro Bioactivities of Essential Oil and Volatile Constituents of Hydrosol from Evodia rutaecarpa
    Xi Liu, Nan Xu, Na Liao +3
    MoleculesPeer-reviewedCC BY 4.0General chemistryCrossref
BibTeX
@article{zhang2026niacinamideceramide,
  title = {{Niacinamide–Ceramide Conjugate: In Vitro Bioactivities and 28-Day Clinical Evidence for Multitarget Skincare}},
  author = {Ziheng Zhang and Zijian Xu and Jingmin Feng and Haoquan Yu and Yanqiu Mu and Chaowen Yang and Ping Zhao},
  journal = {ACS Omega},
  year = {2026},
  month = nov,
  doi = {10.1021/acsomega.6c05537},
  url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c05537/5471098/Niacinamide-Ceramide-Conjugate-In-Vitro},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Niacinamide–Ceramide Conjugate: In Vitro Bioactivities and 28-Day Clinical Evidence for Multitarget Skincare
AU  - Ziheng Zhang
AU  - Zijian Xu
AU  - Jingmin Feng
AU  - Haoquan Yu
AU  - Yanqiu Mu
AU  - Chaowen Yang
AU  - Ping Zhao
PY  - 2026
DA  - 2026/11/16
JO  - ACS Omega
DO  - 10.1021/acsomega.6c05537
UR  - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c05537/5471098/Niacinamide-Ceramide-Conjugate-In-Vitro
AB  - Niacinamide (NAM) and ceramides are well-established skincare ingredients with distinct yet complementary biological mechanisms. Nevertheless, simple physical blending of these two actives presents practical limitations for topical application. To address this, the present study evaluated SuperCera N-Nicotinamide(P) (NAM-Cer), a niacinamide–ceramide covalent conjugate conceived to integrate bioactivities derived from each parent moiety within a single molecular framework. Employing an integrated workflow combining in vitro cellular assays and a 28-day randomized clinical trial, we identified multiple cellular-level bioactivities of NAM-Cer, including elastase inhibition, upregulation of type I collagen (COL1A1) and aquaporin-3 (AQP3), suppression of melanogenesis and tyrosinase activity, and downregulation of matrix metalloproteinase-1 (MMP-1). Clinical evaluation revealed significant, concentration-dependent improvements in skin hydration, elasticity, firmness, brightness, and antiwrinkle efficacy, along with favorable cutaneous tolerability. In summary, NAM-Cer is a safe, multitarget skincare candidate that elicits diverse skin-beneficial bioactivities in vitro and drives concentration-dependent cutaneous improvements in short-term human topical use.
SN  - 2470-1343
ER  -